Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 171

1.

Author Correction: Epoxyeicosatrienoic acids enhance embryonic haematopoiesis and adult marrow engraftment.

Li P, Lahvic JL, Binder V, Pugach EK, Riley EB, Tamplin OJ, Panigrahy D, Bowman TV, Barrett FG, Heffner GC, McKinney-Freeman S, Schlaeger TM, Daley GQ, Zeldin DC, Zon LI.

Nature. 2019 Aug 21. doi: 10.1038/s41586-019-1489-4. [Epub ahead of print]

PMID:
31435017
2.

Effects of statins on multispecies oral biofilm identify simvastatin as a drug candidate targeting Porphyromonas gingivalis.

Kamińska M, Aliko A, Hellvard A, Bielecka E, Binder V, Marczyk A, Potempa J, Delaleu N, Kantyka T, Mydel P.

J Periodontol. 2019 Jun;90(6):637-646. doi: 10.1002/JPER.18-0179. Epub 2018 Dec 26.

PMID:
30506795
3.

Impact of fibrinogen carbamylation on fibrin clot formation and stability.

Binder V, Bergum B, Jaisson S, Gillery P, Scavenius C, Spriet E, Nyhaug AK, Roberts HM, Chapple ILC, Hellvard A, Delaleu N, Mydel P.

Thromb Haemost. 2017 May 3;117(5):899-910. doi: 10.1160/TH16-09-0704. Epub 2017 Apr 6.

4.

CXCR1 remodels the vascular niche to promote hematopoietic stem and progenitor cell engraftment.

Blaser BW, Moore JL, Hagedorn EJ, Li B, Riquelme R, Lichtig A, Yang S, Zhou Y, Tamplin OJ, Binder V, Zon LI.

J Exp Med. 2017 Apr 3;214(4):1011-1027. doi: 10.1084/jem.20161616. Epub 2017 Mar 28.

5.

Carbamylated LL-37 as a modulator of the immune response.

Koro C, Hellvard A, Delaleu N, Binder V, Scavenius C, Bergum B, Główczyk I, Roberts HM, Chapple IL, Grant MM, Rapala-Kozik M, Klaga K, Enghild JJ, Potempa J, Mydel P.

Innate Immun. 2016 Apr;22(3):218-29. doi: 10.1177/1753425916631404. Epub 2016 Feb 15.

6.

Antibodies against carbamylated proteins are present in primary Sjögren's syndrome and are associated with disease severity.

Bergum B, Koro C, Delaleu N, Solheim M, Hellvard A, Binder V, Jonsson R, Valim V, Hammenfors DS, Jonsson MV, Mydel P.

Ann Rheum Dis. 2016 Aug;75(8):1494-500. doi: 10.1136/annrheumdis-2015-207751. Epub 2015 Sep 8.

7.

Epoxyeicosatrienoic acids enhance embryonic haematopoiesis and adult marrow engraftment.

Li P, Lahvic JL, Binder V, Pugach EK, Riley EB, Tamplin OJ, Panigrahy D, Bowman TV, Barrett FG, Heffner GC, McKinney-Freeman S, Schlaeger TM, Daley GQ, Zeldin DC, Zon LI.

Nature. 2015 Jul 23;523(7561):468-71. doi: 10.1038/nature14569. Erratum in: Nature. 2019 Aug 21;:.

8.

Next-generation-sequencing of recurrent childhood high hyperdiploid acute lymphoblastic leukemia reveals mutations typically associated with high risk patients.

Chen C, Bartenhagen C, Gombert M, Okpanyi V, Binder V, Röttgers S, Bradtke J, Teigler-Schlegel A, Harbott J, Ginzel S, Thiele R, Husemann P, Krell PF, Borkhardt A, Dugas M, Hu J, Fischer U.

Leuk Res. 2015 Sep;39(9):990-1001. doi: 10.1016/j.leukres.2015.06.005. Epub 2015 Jun 14.

PMID:
26189108
9.

Variant rs1801157 in the 3'UTR of SDF-1ß does not explain variability of healthy-donor G-CSF responsiveness.

Schulz M, Karpova D, Spohn G, Damert A, Seifried E, Binder V, Bönig H.

PLoS One. 2015 Mar 24;10(3):e0121859. doi: 10.1371/journal.pone.0121859. eCollection 2015.

10.

Carbamylation of immunoglobulin abrogates activation of the classical complement pathway.

Koro C, Bielecka E, Dahl-Knudsen A, Enghild JJ, Scavenius C, Brun JG, Binder V, Hellvard A, Bergum B, Jonsson R, Potempa J, Blom AM, Mydel P.

Eur J Immunol. 2014 Nov;44(11):3403-12. doi: 10.1002/eji.201444869. Epub 2014 Oct 20.

11.

A new workflow for whole-genome sequencing of single human cells.

Binder V, Bartenhagen C, Okpanyi V, Gombert M, Moehlendick B, Behrens B, Klein HU, Rieder H, Ida Krell PF, Dugas M, Stoecklein NH, Borkhardt A.

Hum Mutat. 2014 Oct;35(10):1260-70. doi: 10.1002/humu.22625. Epub 2014 Aug 18.

PMID:
25066732
12.

Next-generation-sequencing-based risk stratification and identification of new genes involved in structural and sequence variations in near haploid lymphoblastic leukemia.

Chen C, Bartenhagen C, Gombert M, Okpanyi V, Binder V, Röttgers S, Bradtke J, Teigler-Schlegel A, Harbott J, Ginzel S, Thiele R, Fischer U, Dugas M, Hu J, Borkhardt A.

Genes Chromosomes Cancer. 2013 Jun;52(6):564-79. doi: 10.1002/gcc.22054. Epub 2013 Mar 18.

PMID:
23508829
13.

The myeloperoxidase product hypochlorous acid generates irreversible high-density lipoprotein receptor inhibitors.

Binder V, Ljubojevic S, Haybaeck J, Holzer M, El-Gamal D, Schicho R, Pieske B, Heinemann A, Marsche G.

Arterioscler Thromb Vasc Biol. 2013 May;33(5):1020-7. doi: 10.1161/ATVBAHA.113.301235. Epub 2013 Mar 14.

14.

Recurrent involvement of ring-type zinc finger genes in complex molecular rearrangements in childhood acute myelogeneous leukemia with translocation t(10;11)(p12;q23).

Ghosh S, Bartenhagen C, Okpanyi V, Gombert M, Binder V, Teigler-Schlegel A, Bradtke J, Röttgers S, Dugas M, Borkhardt A.

Leukemia. 2013 Aug;27(8):1745-8. doi: 10.1038/leu.2013.1. Epub 2013 Jan 9. No abstract available.

PMID:
23299548
15.

A novel mtDNA large-scale mutation clinically exclusively presenting with refractory anemia: is there a chance to predict disease progression?

Binder V, Steenpass L, Laws HJ, Ruebo J, Borkhardt A.

J Pediatr Hematol Oncol. 2012 May;34(4):283-92. doi: 10.1097/MPH.0b013e3182288249. Review.

PMID:
22531495
16.

Myeloperoxidase-derived chlorinating species induce protein carbamylation through decomposition of thiocyanate and urea: novel pathways generating dysfunctional high-density lipoprotein.

Holzer M, Zangger K, El-Gamal D, Binder V, Curcic S, Konya V, Schuligoi R, Heinemann A, Marsche G.

Antioxid Redox Signal. 2012 Oct 15;17(8):1043-52. doi: 10.1089/ars.2011.4403. Epub 2012 May 8.

17.

MiR-125 in normal and malignant hematopoiesis.

Shaham L, Binder V, Gefen N, Borkhardt A, Izraeli S.

Leukemia. 2012 Sep;26(9):2011-8. doi: 10.1038/leu.2012.90. Epub 2012 Mar 29. Review.

PMID:
22456625
18.

Fatal outcome despite full lympho-hematopoietic reconstitution after allogeneic stem cell transplantation in atypical ataxia telangiectasia.

Ghosh S, Schuster FR, Binder V, Niehues T, Baldus SE, Seiffert P, Laws HJ, Borkhardt A, Meisel R.

J Clin Immunol. 2012 Jun;32(3):438-40. doi: 10.1007/s10875-012-9654-7. Epub 2012 Feb 23.

PMID:
22354567
19.

CD34+ gene expression profiling of individual children with very severe aplastic anemia indicates a pathogenic role of integrin receptors and the proapoptotic death ligand TRAIL.

Fischer U, Ruckert C, Hubner B, Eckermann O, Binder V, Bakchoul T, Schuster FR, Merk S, Klein HU, Führer M, Dugas M, Borkhardt A.

Haematologica. 2012 Sep;97(9):1304-11. doi: 10.3324/haematol.2011.056705. Epub 2012 Feb 7.

20.

Array-based sequence capture and next-generation sequencing for the identification of primary immunodeficiencies.

Ghosh S, Krux F, Binder V, Gombert M, Niehues T, Feyen O, Laws HJ, Borkhardt A; PID-NET: German Network on Primary Immunodeficiency Diseases.

Scand J Immunol. 2012 Mar;75(3):350-4. doi: 10.1111/j.1365-3083.2011.02658.x.

21.

Cyanate is a novel inducer of endothelial icam-1 expression.

El-Gamal D, Holzer M, Gauster M, Schicho R, Binder V, Konya V, Wadsack C, Schuligoi R, Heinemann A, Marsche G.

Antioxid Redox Signal. 2012 Jan 15;16(2):129-37. doi: 10.1089/ars.2011.4090. Epub 2011 Oct 14.

22.

Uremia alters HDL composition and function.

Holzer M, Birner-Gruenberger R, Stojakovic T, El-Gamal D, Binder V, Wadsack C, Heinemann A, Marsche G.

J Am Soc Nephrol. 2011 Sep;22(9):1631-41. doi: 10.1681/ASN.2010111144. Epub 2011 Jul 29.

23.

Highly skewed T-cell receptor V-beta chain repertoire in the bone marrow is associated with response to immunosuppressive drug therapy in children with very severe aplastic anemia.

Schuster FR, Hubner B, Führer M, Eckermann O, Gombert M, Dornmair K, Binder V, Reuther S, Krell P, Keller T, Borkhardt A.

Blood Cancer J. 2011 Mar;1(3):e8. doi: 10.1038/bcj.2011.6. Epub 2011 Mar 4.

24.

Expression of cell-cell interacting genes distinguishes HLXB9/TEL from MLL-positive childhood acute myeloid leukemia.

Wildenhain S, Ruckert C, Röttgers S, Harbott J, Ludwig WD, Schuster FR, Beldjord K, Binder V, Slany R, Hauer J, Borkhardt A.

Leukemia. 2010 Sep;24(9):1657-60. doi: 10.1038/leu.2010.146. Epub 2010 Jul 1. No abstract available.

PMID:
20596032
25.

Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53.

Gefen N, Binder V, Zaliova M, Linka Y, Morrow M, Novosel A, Edry L, Hertzberg L, Shomron N, Williams O, Trka J, Borkhardt A, Izraeli S.

Leukemia. 2010 Jan;24(1):89-96. doi: 10.1038/leu.2009.208. Epub 2009 Nov 5.

26.

TNFSF15 polymorphisms are associated with susceptibility to inflammatory bowel disease in a new European cohort.

Thiébaut R, Kotti S, Jung C, Merlin F, Colombel JF, Lemann M, Almer S, Tysk C, O'Morain M, Gassull M, Binder V, Finkel Y, Pascoe L, Hugot JP.

Am J Gastroenterol. 2009 Feb;104(2):384-91. doi: 10.1038/ajg.2008.36. Epub 2009 Jan 13.

PMID:
19174806
27.

Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome.

Bercovich D, Ganmore I, Scott LM, Wainreb G, Birger Y, Elimelech A, Shochat C, Cazzaniga G, Biondi A, Basso G, Cario G, Schrappe M, Stanulla M, Strehl S, Haas OA, Mann G, Binder V, Borkhardt A, Kempski H, Trka J, Bielorei B, Avigad S, Stark B, Smith O, Dastugue N, Bourquin JP, Tal NB, Green AR, Izraeli S.

Lancet. 2008 Oct 25;372(9648):1484-92. doi: 10.1016/S0140-6736(08)61341-0. Epub 2008 Sep 19.

PMID:
18805579
28.

Longitudinal concordance for clinical characteristics in a Swedish-Danish twin population with inflammatory bowel disease.

Halfvarson J, Jess T, Bodin L, Järnerot G, Munkholm P, Binder V, Tysk C.

Inflamm Bowel Dis. 2007 Dec;13(12):1536-44.

PMID:
17828780
29.

Oral graft vs. host disease in children--treatment with topical tacrolimus ointment.

Albert MH, Becker B, Schuster FR, Klein B, Binder V, Adam K, Nienhoff C, Führer M, Borkhardt A.

Pediatr Transplant. 2007 May;11(3):306-11.

PMID:
17430488
30.

Risk factors for colorectal neoplasia in inflammatory bowel disease: a nested case-control study from Copenhagen county, Denmark and Olmsted county, Minnesota.

Jess T, Loftus EV Jr, Velayos FS, Winther KV, Tremaine WJ, Zinsmeister AR, Scott Harmsen W, Langholz E, Binder V, Munkholm P, Sandborn WJ.

Am J Gastroenterol. 2007 Apr;102(4):829-36. Epub 2007 Jan 11.

PMID:
17222314
31.

Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark.

Jess T, Riis L, Vind I, Winther KV, Borg S, Binder V, Langholz E, Thomsen OØ, Munkholm P.

Inflamm Bowel Dis. 2007 Apr;13(4):481-9.

PMID:
17206705
32.

The prevalence of genetic and serologic markers in an unselected European population-based cohort of IBD patients.

Riis L, Vind I, Vermeire S, Wolters F, Katsanos K, Politi P, Freitas J, Mouzas IA, O'Morain C, Ruiz-Ochoa V, Odes S, Binder V, Munkholm P, Moum B, Stockbrügger R, Langholz E; European Collaborative Study Group on Inflammatory Bowel Disease.

Inflamm Bowel Dis. 2007 Jan;13(1):24-32.

PMID:
17206636
33.

The genotype of the original Wiskott phenotype.

Binder V, Albert MH, Kabus M, Bertone M, Meindl A, Belohradsky BH.

N Engl J Med. 2006 Oct 26;355(17):1790-3.

34.

Environmental factors in inflammatory bowel disease: a co-twin control study of a Swedish-Danish twin population.

Halfvarson J, Jess T, Magnuson A, Montgomery SM, Orholm M, Tysk C, Binder V, Järnerot G.

Inflamm Bowel Dis. 2006 Oct;12(10):925-33.

PMID:
17012962
35.

Does pregnancy change the disease course? A study in a European cohort of patients with inflammatory bowel disease.

Riis L, Vind I, Politi P, Wolters F, Vermeire S, Tsianos E, Freitas J, Mouzas I, Ruiz Ochoa V, O'Morain C, Odes S, Binder V, Moum B, Stockbrügger R, Langholz E, Munkholm P; European Collaborative study group on Inflammatory Bowel Disease.

Am J Gastroenterol. 2006 Jul;101(7):1539-45.

PMID:
16863558
36.

Disease concordance, zygosity, and NOD2/CARD15 status: follow-up of a population-based cohort of Danish twins with inflammatory bowel disease.

Jess T, Riis L, Jespersgaard C, Hougs L, Andersen PS, Orholm MK, Binder V, Munkholm P.

Am J Gastroenterol. 2005 Nov;100(11):2486-92.

PMID:
16279904
37.

Intra- and interobserver variation in the use of the Vienna classification of Crohn's disease.

Riis L, Munkholm P, Binder V, Skovgaard LT, Langholz E.

Inflamm Bowel Dis. 2005 Jul;11(7):657-61.

PMID:
15973120
38.

Clinical epidemiology--how important now?

Binder V.

Gut. 2005 May;54(5):574-5. No abstract available.

39.

Enteric-coated mycophenolate sodium delivers bioequivalent MPA exposure compared with mycophenolate mofetil.

Arns W, Breuer S, Choudhury S, Taccard G, Lee J, Binder V, Roettele J, Schmouder R.

Clin Transplant. 2005 Apr;19(2):199-206.

PMID:
15740555
40.

Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County.

Winther KV, Jess T, Langholz E, Munkholm P, Binder V.

Clin Gastroenterol Hepatol. 2004 Dec;2(12):1088-95.

PMID:
15625654
41.

Epidemiology of IBD during the twentieth century: an integrated view.

Binder V.

Best Pract Res Clin Gastroenterol. 2004 Jun;18(3):463-79.

PMID:
15157821
42.

Screening for dysplasia and TP53 mutations in closed rectal stumps of patients with ulcerative colitis or Crohn disease.

Winther KV, Bruun E, Federspiel B, Guldberg P, Binder V, Brynskov J.

Scand J Gastroenterol. 2004 Mar;39(3):232-7.

PMID:
15074392
43.

Intestinal and extra-intestinal cancer in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark.

Jess T, Winther KV, Munkholm P, Langholz E, Binder V.

Aliment Pharmacol Ther. 2004 Feb 1;19(3):287-93.

PMID:
14984375
44.

Survival and cause-specific mortality in ulcerative colitis: follow-up of a population-based cohort in Copenhagen County.

Winther KV, Jess T, Langholz E, Munkholm P, Binder V.

Gastroenterology. 2003 Dec;125(6):1576-82.

PMID:
14724807
45.

Mortality and causes of death in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark.

Jess T, Winther KV, Munkholm P, Langholz E, Binder V.

Gastroenterology. 2002 Jun;122(7):1808-14.

PMID:
12055588
46.

[When nursing care hurts.. It is part of daily experience to be confronted with one form ov violence or another. Student project in nursing research curriculum].

Bauer N, Binder V, Böhm D, Pany N, Zoder K.

Osterr Pflegezeitschrift. 2001 May;54(5):22-3. German. No abstract available.

PMID:
11942075
47.

CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease.

Lesage S, Zouali H, Cézard JP, Colombel JF, Belaiche J, Almer S, Tysk C, O'Morain C, Gassull M, Binder V, Finkel Y, Modigliani R, Gower-Rousseau C, Macry J, Merlin F, Chamaillard M, Jannot AS, Thomas G, Hugot JP; EPWG-IBD Group; EPIMAD Group; GETAID Group.

Am J Hum Genet. 2002 Apr;70(4):845-57. Epub 2002 Mar 1.

48.

IBD: how important are clinical epidemiological studies?

Binder V.

Dig Liver Dis. 2001 Nov;33(8):651-2. No abstract available.

PMID:
11785708
49.

[Therapeutic principles for chronic inflammatory bowel disease].

Binder V, Munkholm P.

Ugeskr Laeger. 2001 Jan 1;163(1):16-21. Review. Danish.

PMID:
11586666
50.

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease.

Hugot JP, Chamaillard M, Zouali H, Lesage S, Cézard JP, Belaiche J, Almer S, Tysk C, O'Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel JF, Sahbatou M, Thomas G.

Nature. 2001 May 31;411(6837):599-603.

PMID:
11385576

Supplemental Content

Loading ...
Support Center